CYAD — Celyad Oncology SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro CapMomentum Trap

Annual balance sheet for Celyad Oncology SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	17.2	30	12.4	7	4.2
Net Total Accounts Receivable
Net Total Receivables	0.907	2.34	1.26	2.78	0.907
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	19.7	34.3	14.8	11.1	6.51
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.12	3.25	0.309	1.83	1.49
Net Goodwill
Net Intangible Assets
Long Term Notes Receivable
Other Long Term Assets
Total Assets	66.1	79.9	19.7	16.3	9.93
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	11.8	13.8	10.4	2.93	2.85
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	35.1	36.3	15.4	9.98	9.42
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Other Equity
Total Equity	31	43.6	4.32	6.3	0.511
Total Liabilities & Shareholders' Equity	66.1	79.9	19.7	16.3	9.93
Total Common Shares Outstanding